Enjoy complimentary customisation on priority with our Enterprise License!
The Thoracic Catheters Market size is estimated to grow by USD 189.62 million at a CAGR of 7.05% between 2023 and 2028. The market's growth is influenced by several factors, including the escalating incidence of pneumothorax and pleural effusion diseases, a growing inclination among patients towards minimally invasive surgical procedures, and favorable health reimbursement policies. These elements collectively drive market expansion, reflecting evolving healthcare needs and regulatory dynamics.
The landscape of thoracic diseases treatment is shaped by several significant factors. The rising incidence of pneumothorax and pleural effusion diseases necessitates advanced diagnostic and treatment options. Simultaneously, patient demand for minimally invasive surgeries is on the rise, leading to the growing importance of less invasive and efficient medical interventions. One such innovation is the utilization of Fractional Flow Reserve (FFR) devices in thoracic surgery. These devices enable accurate assessment of coronary artery function, facilitating more precise interventions and reducing the need for invasive procedures. Thoracic surgery, a specialized field, encompasses various procedures to treat conditions affecting the lungs, esophagus, and chest wall. With the integration of advanced technologies like FFR devices, thoracic surgery is evolving to offer more effective and less invasive treatment solutions for patients. The presence of favorable health reimbursement policies further supports patient access to these innovative treatments.
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 to 2022, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
There is a growing preference among patients towards minimally invasive surgeries due to severe complications related to traditional open surgeries which is significantly contributing to the market growth globally. In addition, open surgical procedures can lead to complications including blood clots, infections, pain, fatigue, and muscle atrophy. Furthermore, the anesthesia administered before an open surgery can lead to sore throat, nausea, and sleepiness. As a result, there is an increasing preference for minimally invasive surgeries such as laparoscopic surgery and robotic surgery are associated with smaller incisions, reduced healthcare costs, lower anesthesia requirements, faster recovery times, shorter hospital stays, and reduced postoperative complications such as intractable ascites and wound infection. Hence, such factors can positively impact the market.
This report extensively covers market segmentation by application (pleural effusion, pneumothorax, and others), product (accessories and catheters), and geography (North America, Europe, Asia, and the Rest of the World (ROW)).
The pleural effusion segment is estimated to witness significant growth during the forecast period. The pleural effusion segment comprises a medical condition in which excess fluid builds up between the parietal and visceral pleural surfaces of the pleura outside the lungs. In addition, it is mainly caused by cancer, pulmonary embolism, infection due to a virus, pneumonia, or heart failure. Furthermore, some of the symptoms include chest pain, dry cough, fever, difficulty in breathing, persistent hiccups, and shortness of breath.
Get a glance at the market contribution of various segments View a PDF Sample
The pleural effusion segment was the largest segment and was valued at USD 161.67 million in 2018. There are mainly two types of pleural effusion, namely transudative pleural effusion and exudative effusion. Transudative pleural effusion is caused due to fluid leakage into the pleural space, whereas exudative effusion caused due to blocked blood vessels or lymph vessels, inflammation, infection, lung injury, and tumors. Furthermore, treatment for pleural effusion comprises draining fluids from the pleural cavity, pleurodesis, and surgery. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
The accessories segment comprises catheter valves, stabilization devices, fixing clamps, adapters, and tubing. connectors. In addition, these accessories are largely commoditized high-volume products and need constant replacement. They are extensively used in tandem with medical devices to augment the process. Furthermore, this segment is purchased in bulk by hospitals and GPOs as part of the cost-cutting strategy. For instance, stabilization devices are used to prevent discomfort associated with the dragging of indwelling catheters. Fixing clamps are used to bind two or more catheters firmly. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
Catheters are thin tubes manufactured from medical-grade materials including silicone rubber, nylon, polyurethane, polyethylene terephthalate (PET), latex, and thermoplastic elastomers. Thoracic catheters are essentially embedded into the thoracic cavity to remove air and fluid from the pleural and pericardial spaces. In addition, they are used to treat medical conditions including pneumothorax, empyema, hemothorax, and pleural effusion. Furthermore, indwelling catheters are adopted to remove fluid, pus, and blood present in the pleural cavity. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. One of the main countries in North America which is significantly contributing to the market growth in North America is the US due to the presence of extensive healthcare insurance coverage, increasing R&D expenditure of companies, and high adoption of technologically advanced products. In addition, several factors such as the strong presence of well-established medical and healthcare infrastructure, the growing aging population, and the rising incidence of pneumothorax and pleural effusion in the country are contributing to the market growth in this region. Hence, such factors are expected to drive the market growth in the region during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
ANGIPLAST Pvt. Ltd: The company offers thoracic catheters with a chest drainage catheter system.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market responds to the rising prevalence of respiratory diseases and cardiovascular diseases, offering essential tools for treatment. With advancements like digital thoracic drainage systems, management of conditions such as spontaneous pneumothorax is more effective. Surge in demand for thoracic drainage devices underscores their significance in urgent care centers and MI procedures. These thoracic drainage systems, including chest wall drainage devices, cater to diverse medical needs, ensuring proper drainage in critical areas like the mediastinum. With the adoption of single-use catheters and self-catheterization, infection risk is minimized, enhancing patient safety. Utilizing materials like polyvinyl chloride, these devices offer reliability and effectiveness in reducing morbidity rates associated with thoracic conditions. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the market growth is the Increasing prevalence of pneumothorax and pleural effusion diseases. Pneumothorax (collapsed lung) can be referred to as a thoracic disorder that occurs when the air is trapped in the pleural cavity between the lungs and the chest wall. Some of the key causes of smoking are lung cancer, asthma, tuberculosis, emphysema, chest injuries, cystic fibrosis, bacterial pneumonia, and chronic obstructive pulmonary disease (COPD).
Pleural effusion, a condition characterized by the accumulation of excess fluid in the pleural cavity, can be caused by various underlying conditions such as cirrhosis, heart failure, pulmonary embolism, lung cancer, breast cancer, kidney disease, bleeding, tuberculosis, and autoimmune diseases. According to the Natural Library of Medicine, approximately 1.5 million new cases are diagnosed annually in the US. This increasing prevalence of pleural effusion and its associated complication, pneumothorax, is driving market growth in the healthcare industry.
Advancements in medical technology are playing a significant role in the diagnosis and treatment of pleural effusion. One such innovation is the use of 3D Cardiac Mapping Systems. These systems provide real-time, high-resolution images of the heart and surrounding structures, enabling healthcare professionals to visualize and analyze the heart's function and identify any anomalies. In pleural effusion, 3D Cardiac Mapping Systems can help diagnose the underlying cause, guide interventional procedures, and monitor treatment progress.
A key factor shaping the market growth is the technological advances in thoracic catheters. Some of the key technological advances in thoracic catheters are the emergence of analog thoracic devices and digital thoracic devices. For instance, analog thoracic devices are used to measure air leaks in a subjective manner, where an observer visualizes the bubbling in the water chamber with the number of columns (1 to 7) to determine the presence and size of air leaks and intrathoracic pressure in pneumothorax, empyema, hemothorax, and pleural effusion patients.
Moreover, digital thoracic devices include digital sensors to continuously monitor airflow and pleural pressure on a graphical display screen to improve clinical outcomes. Furthermore, these devices are used after thoracic surgery to remove air and pleural fluid and to evaluate postoperative air leaks. Hence, such technological advancements are positively impacting the market. Therefore, it is expected to drive the market growth during the forecast period.
The lack of skilled professionals to perform catheter insertion procedure are one of the key challenges hindering the market growth. Experienced and skilled professionals are needed to perform catheter insertion procedures, and they play a crucial role in providing effective treatment. Therefore, the lack of expertise fuels the probability of improper treatment, which can result in catheter-associated infections and non-infectious catheter-related complications such as pain, hemorrhage, and bleeding.
Moreover, factors including aging surgeons, lack of dexterity while performing surgeries, and migration of well-established trained specialists from developing countries to developed countries are responsible for this shortfall. Hence, such factors are negatively impacting the market. Therefore, it will hinder the market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2023 for the following segments
The market addresses critical needs in respiratory care, facilitating treatment for conditions like respiratory failure and acute lung diseases. Vital in mechanical ventilation and surgical support, these catheters play a pivotal role in managing pleural effusions and empyema disorders. Despite a temporary decline in demand, heightened awareness and adoption of minimally invasive techniques bolster the market's resilience. Key players like Teleflex Incorporated and ICU Medical drive product innovation and portfolio expansion, offering advanced solutions like closed chest tube thoracostomies and pleural drainage catheters. With a focus on health insurance coverage and accessories market, the market ensures comprehensive care for patients undergoing thoracic surgery and pulmonology procedures.
Market Scope |
|
Report Coverage |
Details |
Page number |
164 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.05% |
Market growth 2024-2028 |
USD 189.62 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
6.65 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
ANGIPLAST Pvt. Ltd., Argon Medical Devices Inc., ATMOS MedizinTechnik GmbH and Co. KG, Becton Dickinson and Co., Cardinal Health Inc., Cook Group Inc., Diversatek Inc., Getinge AB, intra special catheters GmbH, Koc Holding AS, LivaNova Plc, Medela AG, Merit Medical Systems Inc., PASCO Inc., Redax S.p.A., Rocket Medical Plc, Smiths Group Plc, Sterimed Medical Devices Pvt. Ltd., Teleflex Inc., and Vygon SAS |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.